Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) [Phase 1]

View source ↗

Summary

Phase 1 study of pembrolizumab (MK-3475) in participants with progressive locally advanced/metastatic carcinoma, melanoma, or non-small cell lung carcinoma comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cancer, Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2019-12-13